Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and …
MME Diesveld, DWMJ Pijnenburg, RA Weersink… - European journal of …, 2024 - Springer
Purpose The popularity of direct oral anticoagulants (DOACs) is increasing among patients
with cirrhosis. Cirrhosis has a major impact on the pharmacokinetics of drugs, potentially …
with cirrhosis. Cirrhosis has a major impact on the pharmacokinetics of drugs, potentially …